What's the difference between products liability and product recall coverage?

Products liability is a third-party coverage — it responds when someone outside your company (a patient, end user, or downstream property owner) suffers bodily injury or property damage from your product. The policy pays defense costs, indemnity to the injured party, and judgments or settlements. Limits are typically per-occurrence and aggregate, sized in the millions for life sciences operators.

Product recall coverage is a first-party coverage — it pays you, the manufacturer, for the costs of executing a recall. It does not depend on a third-party claim being filed; the trigger is the recall event itself (FDA-mandated or voluntary). The policy pays your costs of identifying affected lots, notifying downstream purchasers and end customers, retrieving product, destruction and certified disposal, replacement product, regulatory consultant fees, crisis communications, and lost gross profit during the recall period.

A typical recall event sequence: a manufacturer identifies a quality issue (microbial contamination, mislabeling, out-of-spec API, etc.) requiring a Class I or II recall. The recall triggers immediate first-party costs (notification, retrieval, destruction, replacement) covered by the recall policy. As affected product reaches end customers in the days or weeks before retrieval, patient-injury claims surface and trigger the products liability policy.

A CDMO or 503B without recall coverage funds the first-party recall costs out of operating cash while waiting for products liability to respond to any subsequent bodily injury claims. Recall costs alone for a moderate Class II recall frequently exceed $500,000-$2,000,000; for a Class I recall touching multiple hospital systems they routinely reach the multi-million-dollar range. Without recall coverage these costs come straight out of the manufacturer's working capital before any third-party claim is paid.

Most standard products liability policies include an "FDA-recall extension" or "products withdrawal expense" endorsement. This wording can create the impression that the products policy already covers recall costs. In most cases it does not — the extension typically provides a modest sublimit ($100,000-$500,000) for very limited recall-related third-party defense costs, not for the full first-party cost of executing a recall.

The diagnostic check: look at the products policy declarations for the specific endorsement form number and sublimit. If the sublimit is under $500,000 and the wording references "products withdrawal expense" or "FDA recall coverage," the operator does not have meaningful recall coverage — it has a token extension. Standalone recall policies with $1M-$5M first-party limits are the structural fix.

Both coverages are structural for: medical device manufacturers (especially Class II/III implantables and high-risk devices), pharmaceutical manufacturers, 503B outsourcing facilities, supplement and OTC makers, and any operator with FDA-regulated finished product entering commerce. The products liability tower handles the third-party claims dimension; the standalone recall policy handles the first-party recall execution dimension.

Operators sometimes carry only products liability and rely on the FDA-recall extension. This works at very small scale (single product, low volume, single distribution channel) but becomes structurally inadequate as soon as the operator scales to multi-product, multi-hospital, or multi-channel distribution.

For a Texas 503B at $20M revenue: products liability tower at $5M-$10M typically runs $30,000-$80,000 annually. A standalone recall policy at $1M-$5M typically runs $8,000-$35,000 annually. The recall premium is meaningfully smaller than the products premium but covers exposure that products doesn't touch. Buyers focused on minimizing total premium often skip the standalone recall policy and discover at first recall event that the FDA-recall extension is structurally inadequate.